Health
Drug May Reduce Tumor Volume in Neurofibromatosis – Technology Networks
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume…
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1). The results of the Phase 2 clinical trial, co-chaired by Michael J. Fisher, MD at CHOP, were published recently in Nature Medicine.
“This is the second…
-
General18 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General22 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News22 hours agoOne Nation leader Pauline Hanson calls out supermarket giants for ‘fleecing’ customers with ‘flimsy’ paper bags
-
Noosa News17 hours agoNorman Dean Lake refused bail for allegedly threatening to kill Prime Minister Anthony Albanese